Ju Cui

915 total citations
50 papers, 627 citations indexed

About

Ju Cui is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Ju Cui has authored 50 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Cell Biology and 6 papers in Immunology. Recurrent topics in Ju Cui's work include Microtubule and mitosis dynamics (4 papers), Immune Cell Function and Interaction (4 papers) and RNA modifications and cancer (4 papers). Ju Cui is often cited by papers focused on Microtubule and mitosis dynamics (4 papers), Immune Cell Function and Interaction (4 papers) and RNA modifications and cancer (4 papers). Ju Cui collaborates with scholars based in China, Hong Kong and United States. Ju Cui's co-authors include Huan Gong, Tiemei Zhang, Jing Pang, Jian‐Dong Huang, Xiuqing Huang, Chao Xi, Tao Shen, Zai Wang, Raozhou Lin and Jian‐Ping Cai and has published in prestigious journals such as PLoS ONE, Development and Diabetes.

In The Last Decade

Ju Cui

48 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju Cui China 15 273 100 87 86 64 50 627
Shuai Yan China 14 220 0.8× 47 0.5× 88 1.0× 52 0.6× 49 0.8× 38 687
Roberto Buccafusca United States 14 305 1.1× 58 0.6× 66 0.8× 56 0.7× 33 0.5× 23 710
Jihang Zhang China 18 343 1.3× 76 0.8× 90 1.0× 130 1.5× 48 0.8× 74 959
Jingwei Chen China 14 342 1.3× 65 0.7× 64 0.7× 41 0.5× 45 0.7× 45 764
Jiaying Yang China 18 267 1.0× 37 0.4× 97 1.1× 33 0.4× 66 1.0× 57 869
Timothy Connor Australia 16 503 1.8× 101 1.0× 260 3.0× 57 0.7× 40 0.6× 36 833
Yueh‐Chiao Yeh Taiwan 14 301 1.1× 38 0.4× 54 0.6× 109 1.3× 82 1.3× 32 768
Ka Bian China 15 458 1.7× 47 0.5× 170 2.0× 83 1.0× 77 1.2× 44 949
Qi Kang China 17 285 1.0× 24 0.2× 85 1.0× 71 0.8× 73 1.1× 57 752

Countries citing papers authored by Ju Cui

Since Specialization
Citations

This map shows the geographic impact of Ju Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Cui more than expected).

Fields of papers citing papers by Ju Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Cui. The network helps show where Ju Cui may publish in the future.

Co-authorship network of co-authors of Ju Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Ju Cui. A scholar is included among the top collaborators of Ju Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju Cui. Ju Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cui, Ju, Jing Pang, Liqun Zhang, et al.. (2024). PENG ZU Study on Healthy Aging in China (PENG ZU Cohort): Design and Goals. China CDC Weekly. 6(34). 876–882. 1 indexed citations
3.
Li, Wenlin, Kun Xu, Junpeng Gao, et al.. (2024). The dual functions of the pentacyclic triterpenoid madecassic acid in ameliorating doxorubicin-induced cardiotoxicity and enhancing the antitumor efficacy of doxorubicin. International Journal of Biological Sciences. 20(14). 5396–5414. 3 indexed citations
4.
Li, Jin, He Zhang, Zhenhe Wang, et al.. (2023). 8-oxo-dGTP curbs tumor development via S phase arrest and AIF-mediated apoptosis. Free Radical Biology and Medicine. 196. 53–64. 3 indexed citations
5.
Huo, Da, Chi Zhang, Liqun Zhang, et al.. (2023). Serum glycoprotein non-metastatic melanoma protein B (GPNMB) level as a potential biomarker for diabetes mellitus-related cataract: A cross-sectional study. Frontiers in Endocrinology. 14. 1110337–1110337. 4 indexed citations
6.
Zhang, Yulian, Xiuhong Wang, Ju Cui, et al.. (2023). Targeted IFNγ induction by a genetically engineered Salmonella typhimurium is the key to the liver metastasis inhibition in a mouse model of pancreatic neuroendocrine tumor. Frontiers in Medicine. 10. 1284120–1284120. 1 indexed citations
7.
Qian, Jianchang, et al.. (2022). Enzymatic activity on valsartan of 38 CYP2C9 variants from the Chinese population. Chemico-Biological Interactions. 353. 109799–109799. 4 indexed citations
8.
Jiang, Shan, Ju Cui, Liqun Zhang, et al.. (2022). Role of a Urinary Biomarker in the Common Mechanism of Physical Performance and Cognitive Function. Frontiers in Medicine. 9. 816822–816822. 2 indexed citations
10.
Zhang, Li‐Qun, Yao Xiao, X.‐Y. Zhou, Ju Cui, & Jianping Cai. (2020). Identification of the novel HLA‐A*30:171 allele in a volunteer donor from the China Marrow Donor Program. HLA. 96(6). 721–722. 1 indexed citations
11.
Zhao, Ban, et al.. (2020). The relationship between sclerostin and carotid artery atherosclerosis in patients with stage 3–5 chronic kidney disease. International Urology and Nephrology. 52(7). 1329–1336. 10 indexed citations
12.
Zhang, Li‐Qun, Yao Xiao, X.‐Y. Zhou, Ju Cui, & Jianping Cai. (2019). Characterization of the novel HLA‐DRB1*11:245 allele by sequencing‐based typing. HLA. 93(2-3). 133–134. 3 indexed citations
13.
Sun, Ying, Ban Zhao, Ju Cui, et al.. (2019). Impact of serum fibroblast growth factor(FGF)23 and carotid intima-media thickness on long-term outcome in maintenance hemodialysis patients. Zhonghua laonian yixue zazhi. 38(7). 769–774.
14.
Zhang, Li‐Qun, Yao Xiao, X.‐Y. Zhou, Ju Cui, & Jianping Cai. (2019). Characterization of the novel HLA‐DQB1*03:01:45 allele by sequencing‐based typing. HLA. 93(2-3). 136–137. 3 indexed citations
15.
Zhang, Li‐Qun, Yao Xiao, X.‐Y. Zhou, et al.. (2019). Identification of the novel HLA‐A*30:01:13 allele in a volunteer donor from the China Marrow Donor Program. HLA. 94(4). 370–371. 2 indexed citations
16.
Yu, Xiaoxue, Yang Ruan, Xiuqing Huang, et al.. (2019). Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes. Biochemical and Biophysical Research Communications. 523(1). 140–146. 75 indexed citations
17.
Cui, Ju, Guoxiang Jin, Bin Yu, et al.. (2015). Stable knockdown of Kif5b in MDCK cells leads to epithelial–mesenchymal transition. Biochemical and Biophysical Research Communications. 463(1-2). 123–129. 2 indexed citations
18.
Cui, Ju. (2013). Study on effect of the total flavonoids from Gnaphlium affine D.C. on metabolism of glucose and lipids in diabetic mice. Science and Technology of Food Industry. 1 indexed citations
19.
Peng, Dantao, et al.. (2013). Hyperphosphorylation of Tau Protein in Hippocampus of Central Insulin-Resistant Rats is Associated with Cognitive Impairment. Cellular Physiology and Biochemistry. 32(5). 1417–1425. 35 indexed citations
20.
Cui, Ju, Longtao Wu, Siu‐Ming Chan, & Ka Hou Chu. (2013). cDNA cloning and mRNA expression of retinoid-X-receptor in the ovary of the shrimp Metapenaeus ensis. Molecular Biology Reports. 40(11). 6233–6244. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026